Hims & Hers Health Semaglutide Project
Sector: Healthcare • Location: United States
Source: The Globe and Mail
Hims & Hers Health has been involved in the weight loss drug market, particularly with semaglutide. The company saw significant revenue growth due to drug shortages but faced challenges when the FDA removed semaglutide from its shortage list, impacting its ability to sell compounded versions.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | Cancelled |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | Hims & Hers Health has been involved in the weight loss drug market, particularly with semaglutide. The company saw significant revenue growth due to drug shortages but faced challenges when the FDA removed semaglutide from its shortage list, impacting its ability to sell compounded versions. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |